Role of PCSK9 in breast cancer: a systematic review of its mechanistic pathways and clinical relevance

Meidi Utami Puteri, Vicko Suswidiantoro, Rahma Nabila, Renata Setiawan, Nuriza Ulul Azmi, Fadlina Chany Saputri, Yukihide Watanabe, Mitsuyasu Kato · 2026

Read Role of PCSK9 in breast cancer: a systematic review of its mechanistic pathways and clinical relevance by Meidi Utami Puteri, Vicko Suswidiantoro, Rahma Nabila, Renata Setiawan, Nuriza Ulul Azmi, Fadlina Chany Saputri, Yukihide Watanabe, Mitsuyasu Kato (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13518365.txt.

Description

IntroductionBreast cancer is a heterogeneous disease in which accurate classification based on biomarker expression is essential for effective therapeutic decision-making. Consequently, the identification of novel biomarkers remains a research priority. Proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regulator of low-density lipoprotein (LDL) metabolism via its interaction with the LDL receptor (LDLR), has been extensively studied in cardiovascular disease.

Catalog record

CREATORMeidi Utami Puteri, Vicko Suswidiantoro, Rahma Nabila, Renata Setiawan, Nuriza Ulul Azmi, Fadlina Chany Saputri, Yukihide Watanabe, Mitsuyasu Kato
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13518365

Browse the full library · About the Tower of Babel